Clinical Trials Directory

Explore 6,658 clinical trials worldwide

Showing 1-50 of 6,658 trials

Active filters:Phase: Phase 1Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (6,658)

NCT06708767
Safety Study of CZ10 in Healthy Volunteers
PHASE1Not yet recruiting
24 participants
Started: Jan 31, 2050 · Completed: Jan 31, 2054
1 condition1 sponsor0 locations
NCT05662904
Genetic Ablation of CD33 in HSC to Broaden the Therapeutic Index of CD33-directed Immunotherapy in Patients with AML
PHASE1Not yet recruiting
12 participants
Started: Jan 31, 2028 · Completed: Jan 31, 2030
1 condition3 sponsors2 locations
NCT04933422
CM93 Treatment in Subjects With Epidermal Growth Factor Receptor (EGFR)-Modified Recurrent Glioblastoma (rGBM)
PHASE1Not yet recruiting
72 participants
Started: Jan 31, 2027 · Completed: Jul 31, 2029
1 condition1 sponsor0 locations
NCT06839729
Addressing Parental Tobacco Use in Somali Immigrant Families: Adapting an Evidence-Based Intervention in Primary Care
PHASE1Not yet recruiting
50 participants
Started: Jan 1, 2027 · Completed: Dec 31, 2029
2 conditions1 sponsor0 locations
NCT04903795
Bispecific T Cell Engager BRiTE for Patients With Grade IV Malignant Glioma
PHASE1Not yet recruiting
18 participants
Started: Dec 31, 2026 · Completed: Dec 31, 2027
2 conditions1 sponsor1 location
NCT04366115
Evaluating AVM0703 for Treatment of COVID-19 or Influenza-mediated ARDS
PHASE1Not yet recruiting
16 participants
Started: Dec 1, 2026 · Completed: Mar 1, 2032
3 conditions2 sponsors0 locations
NCT05048368
Pharmacokinetics Study of Larotinib in Subjects With Impaired Hepatic Function
PHASE1Not yet recruiting
32 participants
Started: Oct 30, 2026 · Completed: Dec 30, 2026
2 conditions1 sponsor1 location
NCT06881888
Intranasal Delivery of Octreotide for Treatment of Diabetic Macular Edema
PHASE1Not yet recruiting
60 participants
Started: Aug 31, 2026 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06600880
Neuronavigation-guided FUS-induced BBB Opening in Alzheimer's Disease Patients and Its Effects on Brain Amyloid and Tau
PHASE1Not yet recruiting
6 participants
Started: Aug 31, 2026 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT04035629
129Xe MRI in Pediatric Population With BPD
PHASE1Not yet recruiting
30 participants
Started: Aug 1, 2026 · Completed: Dec 31, 2031
1 condition2 sponsors1 location
NCT06647277
Fecal MicrobiotaTransplant for the Treatment of Parkinson's Disease
PHASE1Not yet recruiting
10 participants
Started: Jul 31, 2026 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06955130
Lactate and Glycerol Contribution to Gluconeogenesis
PHASE1Not yet recruiting
48 participants
Started: Jul 1, 2026 · Completed: Apr 30, 2030
3 conditions1 sponsor0 locations
NCT07203898
A Study of IPM514 in Patients With Esophageal Squamous Cell Carcinoma.
PHASE1Not yet recruiting
36 participants
Started: Jun 30, 2026 · Completed: Jun 30, 2027
1 condition1 sponsor0 locations
NCT07137338
A Phase 1 AAV Gene Therapy Trial Evaluating Safety and Preliminary Efficacy of RP-A701 in Subjects With BAG3 Dilated Cardiomyopathy
PHASE1Not yet recruiting
8 participants
Started: Jun 30, 2026 · Completed: Jun 30, 2029
1 condition1 sponsor0 locations
NCT06297213
R-2487 in Patients With Sjogren's Syndrome (SS)
PHASE1Not yet recruiting
36 participants
Started: Jun 1, 2026 · Completed: Aug 30, 2028
3 conditions1 sponsor0 locations
NCT04419909
Retreatment With CTL019/CTL119
PHASE1Not yet recruiting
12 participants
Started: May 31, 2026 · Completed: Jul 31, 2028
1 condition1 sponsor1 location
NCT06996119
Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant
PHASE1Not yet recruiting
15 participants
Started: May 25, 2026 · Completed: May 25, 2027
3 conditions2 sponsors1 location
NCT06325150
The Impact of Light Exposure on Cognitive Function in Classrooms
PHASE1Not yet recruiting
300 participants
Started: May 16, 2026 · Completed: Feb 1, 2028
1 condition1 sponsor1 location
NCT07020533
A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
PHASE1Not yet recruiting
46 participants
Started: May 8, 2026 · Completed: Jun 1, 2027
12 conditions2 sponsors3 locations
NCT06012487
Correlates and Control of Blood Pressure Variability
PHASE1Not yet recruiting
10 participants
Started: May 1, 2026 · Completed: Dec 31, 2026
1 condition1 sponsor0 locations
NCT07218549
Evaluation of the Safety and Effects of Psychoactive Substances in People With Past Opioid Use
PHASE1Not yet recruiting
50 participants
Started: May 1, 2026 · Completed: May 31, 2029
3 conditions2 sponsors1 location
NCT07040982
Asciminib as Maintenance Treatment After Cellular Therapies for Adults With Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
PHASE1Not yet recruiting
30 participants
Started: May 1, 2026 · Completed: Jun 13, 2028
1 condition2 sponsors1 location
NCT06802523
Testing the Combination of Targeted Radiotherapy With Anti-Cancer Drugs, Venetoclax and ASTX-727, to Improve Outcomes for Adults With Newly Diagnosed Acute Myeloid Leukemia
PHASE1Recruiting
53 participants
Started: Apr 21, 2026 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT06507904
A Study to Learn How Different Preparations of Osivelotor Taste and Enter the Blood With Food or Liquids or With an Antacid in Healthy Adults
PHASE1Not yet recruiting
52 participants
Started: Apr 17, 2026 · Completed: Oct 31, 2026
1 condition1 sponsor0 locations
NCT05093972
Ulonivirine (MK-8507) in Participants With Mild or Moderate Hepatic Impairment (MK-8507-014)
PHASE1Not yet recruiting
22 participants
Started: Apr 7, 2026 · Completed: Sep 10, 2026
1 condition1 sponsor0 locations
NCT05238961
Neuroinflammation in Asymptomatic Carotid Artery Disease - Imaging Substudy
PHASE1Recruiting
20 participants
Started: Apr 1, 2026 · Completed: Dec 31, 2027
2 conditions1 sponsor1 location
NCT03258658
Safety and Feasibility Study of Autologous Engineered Urethral Constructs for the Treatment of Strictures
PHASE1Recruiting
10 participants
Started: Mar 31, 2026 · Completed: Dec 31, 2029
4 conditions2 sponsors2 locations
NCT06746831
Methamphetamine Isomer Pharmacology in Humans
PHASE1Not yet recruiting
17 participants
Started: Mar 31, 2026 · Completed: Mar 31, 2028
1 condition2 sponsors1 location
NCT07183852
Locoregional or Systemic Administration of Autologous Tumor Infiltrating Lymphocytes in Patients With Metastatic Melanoma
PHASE1Not yet recruiting
18 participants
Started: Mar 31, 2026 · Completed: Mar 31, 2033
2 conditions1 sponsor0 locations
NCT03463239
Bioengineered Penile Tissue Constructs for Irreversibly Damaged Penile Corpora
PHASE1Not yet recruiting
10 participants
Started: Mar 31, 2026 · Completed: Jul 31, 2027
6 conditions2 sponsors1 location
NCT05038098
Magnetic Sentinel Lymph Node Mapping in Gastric Cancer
PHASE1Not yet recruiting
20 participants
Started: Mar 31, 2026 · Completed: Feb 2, 2027
1 condition1 sponsor1 location
NCT07187869
Modulation of the Bone Immune Microenvironment Following Cabozantinib Treatment of Bone Metastatic Clear Cell Renal Cell Carcinoma: Proof of Concept Study
PHASE1Not yet recruiting
16 participants
Started: Mar 31, 2026 · Completed: Apr 7, 2029
1 condition2 sponsors0 locations
NCT03606538
MDMA in Subjects With Moderate Hepatic Impairment and Subjects With Normal Hepatic Function
PHASE1Not yet recruiting
16 participants
Started: Mar 29, 2026 · Completed: Dec 31, 2028
2 conditions1 sponsor1 location
NCT06148038
CBD for Breast Cancer Primary Tumors
PHASE1Not yet recruiting
60 participants
Started: Mar 1, 2026 · Completed: Jan 1, 2028
1 condition1 sponsor0 locations
NCT05976555
Phase I Trial of BCMA-TGF-BETA CAR-T Cells in Relapsed, Refractory Myeloma
PHASE1Not yet recruiting
30 participants
Started: Mar 1, 2026 · Completed: May 31, 2029
1 condition1 sponsor0 locations
NCT07041203
Extended-release Sodium Oxybate (Lumryz) in Spasmodic Dysphonia and Voice Tremor
PHASE1Not yet recruiting
8 participants
Started: Mar 1, 2026 · Completed: Jul 31, 2026
3 conditions1 sponsor1 location
NCT05094011
Evaluating Safety, Tolerability, and Efficacy of Autologous MitoCell Transplantation in Subjects With Idiopathic Parkinson's Disease
PHASE1Not yet recruiting
9 participants
Started: Mar 1, 2026 · Completed: Jul 31, 2028
1 condition1 sponsor0 locations
NCT07199413
Allogeneic, Antigen-Presenting, GM-CSF-secreting, SV-BR-1-GM Whole Cell-Therapeutic Vaccine and Immunotherapy: A Phase I Pilot Safety and Feasibility Study for Solid Tumor Patients With CNS Metastases
PHASE1Not yet recruiting
20 participants
Started: Mar 1, 2026 · Completed: Apr 1, 2029
2 conditions1 sponsor0 locations
NCT06649864
Adipose-Derived Mesenchymal Stem Cell for Preventing Biliary Complications
PHASE1Not yet recruiting
20 participants
Started: Feb 28, 2026 · Completed: Jun 30, 2028
2 conditions1 sponsor1 location
NCT07204171
Phase 1 Study of Oral MG001
PHASE1Not yet recruiting
32 participants
Started: Feb 28, 2026 · Completed: Aug 31, 2026
1 condition3 sponsors1 location
NCT07025564
MiRisten for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
PHASE1Recruiting
12 participants
Started: Feb 28, 2026 · Completed: Apr 8, 2027
2 conditions2 sponsors1 location
NCT06978062
Peri-operative Treatment of Resectable Gastroesophageal Cancer Using Bemarituzumab (BEMA) Plus Perioperative Treatment
PHASE1Not yet recruiting
27 participants
Started: Feb 20, 2026 · Completed: Sep 28, 2029
1 condition1 sponsor0 locations
NCT07101432
Phase I Study of Preconditioning Radiation Therapy With IL-15 Transduced TGFBR2 KO CAR.TROP2-engineered Cord Blood-derived NK Cells in Patients With Advanced Head and Neck Cancer (RADIANCE-NK)
PHASE1Not yet recruiting
33 participants
Started: Feb 8, 2026 · Completed: Dec 31, 2029
1 condition1 sponsor1 location
NCT06859008
Zanubrutinib in Combination With Sonrotoclax for the Treatment of Underrepresented Ethnic and Racial Minorities With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
PHASE1Recruiting
37 participants
Started: Feb 7, 2026 · Completed: Jan 31, 2029
19 conditions2 sponsors1 location
NCT07218913
Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors
PHASE1Not yet recruiting
44 participants
Started: Feb 4, 2026 · Completed: Feb 17, 2030
7 conditions2 sponsors1 location
NCT06886737
Home-based Vision Therapy
PHASE1Not yet recruiting
45 participants
Started: Feb 2, 2026 · Completed: Sep 30, 2028
1 condition1 sponsor1 location
NCT07053319
SGLT2i, Pioglitazone, and Ketone Production in T2D
PHASE1Recruiting
64 participants
Started: Feb 1, 2026 · Completed: Jun 30, 2027
1 condition2 sponsors1 location
NCT07016971
CBG/CBD Oil for Chemotherapy-Induced Peripheral Neuropathy
PHASE1Not yet recruiting
12 participants
Started: Feb 1, 2026 · Completed: May 1, 2029
1 condition1 sponsor1 location
NCT06953388
Understanding Non-invasive Vagus Nerve Stimulation Effects in PTSD
PHASE1Not yet recruiting
60 participants
Started: Feb 1, 2026 · Completed: Dec 31, 2032
1 condition1 sponsor1 location
NCT07218367
Phase I Trial of pH Resections of GBM at VA
PHASE1Not yet recruiting
12 participants
Started: Feb 1, 2026 · Completed: Feb 1, 2031
1 condition2 sponsors1 location